Award
Delivery Order #SPE2DR26F9QR9
Delivery Order for Ondansetron Tablets under Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$527.94
Ceiling
$527.94
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26F9QR9
NAICS
424210
This award represents a definitive delivery order contract issued under an existing indefinite delivery vehicle with AmerisourceBergen Drug Corp, a major pharmaceutical distribution company specializing in supplying medications and health care products. The contract covers the procurement of Ondansetron ODT 8 mg tablets, a medication commonly used to prevent nausea and vomiting, highlighting its critical role in patient care support. The order specifies the delivery of this pharmaceutical product to a designated location in Conshohocken, PA, with performance occurring over a short, defined timeframe in early 2026. This delivery order is part of a substantial long-term pharmaceutical supply agreement aimed at improving the agency's access to essential medications through efficient distribution channels. No competitive bidding details are noted for this specific delivery order, which functions within the scope of the overarching contract. As a focused procurement action, it exemplifies the ongoing execution of supply commitments under the larger contract framework established with AmerisourceBergen Drug Corp.
Description
4570811669!ONDANSETRON ODT 8 MG TABLET 30S